Serum creatinine and symmetric dimethylarginine (SDMA) can confidently diagnose middle- to late-stage chronic kidney disease (CKD) in cats but fail to capture the mechanisms behind the disease, according to researchers at The Ohio State University who suggested that measuring more than 2,000 urine proteins could help fill that diagnostic gap.1 Researchers analyzed urine collected by cystocentesis from 64 client-owned cats: 30 healthy cats and 34 cats with stable CKD. The team identified 2,219 proteins in feline urine. Among them, matrix metalloproteinase-7 (MMP-7) emerged as a possible marker of early disease. When the investigators compared the overall urine protein profiles of individual cats, rather than examining proteins one at a time, 3 notable subgroups with distinct protein profiles appeared among cats with CKD. The authors said the subgroups suggested that different disease mechanisms may underlie different forms of feline CKD. The findings were published in the Journal of Proteome Research.1 Why look past single markers The authors noted that creatinine is influenced by muscle mass, which often declines as disease progresses. SDMA's full biological variability is not yet completely understood, the authors added. As a result of these limitations, early-stage CKD remains more difficult to diagnose.1 CKD is also a nonspecific term that does not indicate the cause of
Urine protein patterns may help subtype chronic kidney disease in cats

Excerpt published under fair use for commentary. Full article at dvm360.com.
Read the full story